BlackRock Health Sciences Trust (BME)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

BlackRock Health Sciences Trust (BME) is down 1.2% since the beginning of the year. At $39 per share, BME is trading 8.0% below its 52-week high of $43. Investors who bought $1,000 worth of BME shares 5 years ago would now be looking at an investment worth $1,165.

BlackRock Health Sciences Trust (BME) has returned -1.24% so far this year and 17.81% over the past 12 months. Over the last ten years, BME has returned 7.66% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.

Based on dividend-adjusted daily data since Mar 29, 2005, BME's average daily return is +0.05%, while the average monthly return is +0.97%. At this rate, an investment would double in approximately 6.0 years.

Historically, 63% of months were positive and 38% were negative. The best month was Dec 2008 with a return of +16.1%, while the worst month was Sep 2015 at -18.8%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 4 months.

On a daily basis, BME closed higher 52% of trading days. The best single day was Mar 25, 2020 with a return of +15.0%, while the worst single day was Nov 20, 2008 at -13.6%.

BlackRock Health Sciences Trust has an annualized alpha of 6.29%, beta of 0.59, and R2 of 0.29 versus S&P 500 Index. Calculated based on daily prices since March 30, 2005.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (91.04%) than losses (83.34%) - typical of diversified or defensive assets.
• Beta of 0.59 may look defensive, but with R2 of 0.29 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.29 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BME ranks 75 for risk / return — better than 75% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for BlackRock Health Sciences Trust (BME) and compare them to S&P 500 Index.

BlackRock Health Sciences Trust provided a 8.00% dividend yield over the last twelve months, with an annual payout of $3.15 per share. The company has been increasing its dividends for 8 consecutive years.

The table displays the monthly dividend distributions for BlackRock Health Sciences Trust. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the BlackRock Health Sciences Trust. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BlackRock Health Sciences Trust was 42.03%, occurring on Nov 20, 2008. Recovery took 263 trading sessions.

The current BlackRock Health Sciences Trust drawdown is 5.88%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of BlackRock Health Sciences Trust over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how BlackRock Health Sciences Trust is priced in the market compared to other companies in the Asset Management industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.